| Sources | Names Used |
|---|---|
| CTRPv2 | ML334 diastereomer |
| PharmacoGx | ML334 diastereomer |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHF5A | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | OLFM1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | NKX3-2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | LAMB3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | ZNF131 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | TFIP11 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | FBXL4 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | ANK2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.09 |
| mRNA | TMEM41A | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | HIST1H1T | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
